Glycans in Drug Design

Glycans are elements of numerous bio-therapeutic mediators, ranging from natural products to molecules based on rational plan to recombinant glycoproteins. The glycan components of these agents can be important aspects of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology includes a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids and some selected other plant proteins that are skilful of connecting with endogenous or foreign (macro) molecules. The eminence of the research is on protein-carbohydrate interaction and their involvement in signalling procedures in plants or in plant protection. Based on the formed fundamental alertness new methods are being industrialised to shield crop plants against pests and diseases

  • Membrane biophysics
  • Systems biology
  • Enzyme synthesis
  • Biophysical approaches to cell biology

Related Conference of Glycans in Drug Design

March 15-16, 2021

12th Tissue Repair and Regeneration Congress

Dubai, UAE
March 28-29, 2021

11th Glycobiology World Congress

Vienna, Austria
April 19-19, 2021

2nd International Conference on Nucleic Acids

London, UK
June 11-12, 2021

25th Global Congress on Biotechnology

Berlin, Germany
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland

Glycans in Drug Design Conference Speakers

Recommended Sessions

Related Journals

Are you interested in